By Silvia
In Uncategorized Posted TBVI submission EC AMR consultation March 2022
Recommendations of TBVI for the European Commission call for evidence on: Antimicrobial resistance – Recommendation for greater action
Recommendations of TBVI for the European Commission call for evidence on: Antimicrobial resistance – Recommendation for greater action
To eliminate TB globally, new effective and affordable vaccines are needed. Please read the roadmap that lists the actions needed to accelerate TB R&.
Biofabri and Bharat Biotech partner to develop, manufacture and distribute a novel TB vaccine, MTBVAC
Joint press release Global Forum in Toulouse.
As representatives of communities affected by TB– including survivors, researchers and civil society organizations – we demand long overdue global investments in TB vaccine research and [...]
From 22-25 February, the global tuberculosis (TB) vaccine community will come together for the 6th Global Forum on TB Vaccines, an official event of the French Presidency of the European Union.
The draft programme of the annual TBVI meeting, will be held in Les Diablerets, Switzerland from 6 – 7 April 2022 is available here.
Horizon Europe work programmes could contribute to filling research gaps for Poverty Related and Neglected Diseases. How? Read more about it: “Filling the Global Health Gaps – How [...]
The Healthcare Research Institute of Santiago de Compostela, Hospital Clínico Universitario de Santiago and Biofabri are offering a training opportunity in applied vaccinology. To apply and for [...]
Due to the current Covid situation we deeply regret that we have had to decide to postpone the annual TBVI meeting. We will soon update the website with new information.
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: 0031 (0)6 1099 5196